---
layout: post
title: "Food and Drug Administration Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development; Public Meeting; Request for Comments"
date: 2026-02-05 19:08:10 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-00829
original_published: 2020-01-21 00:00:00 +0000
significance: 8.00
---

# Food and Drug Administration Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development; Public Meeting; Request for Comments

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** January 21, 2020 00:00 UTC
**Document Number:** 2020-00829

## Summary

The Food and Drug Administration (FDA or the Agency) is announcing a public meeting and an opportunity for public comment on "FDA Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development." Developing a treatment for a rare disease can present unique challenges. The goal of this meeting is to obtain stakeholders' perspectives on challenges and solutions in rare disease product development and identify commonalities that can support product development across a variety of rare diseases.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/01/21/2020-00829/food-and-drug-administration-rare-disease-day-2020-supporting-the-future-of-rare-disease-product)
- API: https://www.federalregister.gov/api/v1/documents/2020-00829

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
